Literature DB >> 29242956

[Odontogenic tumours and bone tumours of the jaw : Changes in the new WHO classification].

D Baumhoer1.   

Abstract

At the beginning of 2017, the fourth edition of the WHO Classification of Head and Neck Tumours was published, 12 years after the previous version. Notably, various changes introduced in the third edition have been revised so in some aspects the current classification has more similarities to the second edition of 1992 than to the third edition. A central goal of the editors was to create a classification that can be used worldwide. Molecular findings have therefore been included and updated but are not mandatory for establishing a diagnosis. This article discusses and comments on the most important changes implemented in the classification of gnathic lesions.

Entities:  

Keywords:  Ameloblastoma; Bone neoplasms; Head and neck neoplasms; Odontogenic Tumors; World Health Organization

Mesh:

Year:  2018        PMID: 29242956     DOI: 10.1007/s00292-017-0398-2

Source DB:  PubMed          Journal:  Pathologe        ISSN: 0172-8113            Impact factor:   1.011


  19 in total

1.  Update from the 4th Edition of the World Health Organization Classification of Head and Neck Tumours: Odontogenic and Maxillofacial Bone Tumors.

Authors:  John M Wright; Marilena Vered
Journal:  Head Neck Pathol       Date:  2017-02-28

Review 2.  Odontogenic tumors, WHO 2005: where do we go from here?

Authors:  John M Wright; Edward W Odell; Paul M Speight; Takashi Takata
Journal:  Head Neck Pathol       Date:  2014-11-20

3.  Underestimated PTCH1 mutation rate in sporadic keratocystic odontogenic tumors.

Authors:  Jiafei Qu; Feiyan Yu; Yingying Hong; Yanyan Guo; Lisha Sun; Xuefen Li; Jianyun Zhang; Heyu Zhang; Ruirui Shi; Feng Chen; Tiejun Li
Journal:  Oral Oncol       Date:  2014-11-18       Impact factor: 5.337

Review 4.  Sclerosing odontogenic carcinoma: current diagnostic and management considerations concerning a most unusual neoplasm.

Authors:  M Hanisch; D Baumhoer; S Elges; L F Fröhlich; J Kleinheinz; S Jung
Journal:  Int J Oral Maxillofac Surg       Date:  2017-06-20       Impact factor: 2.789

5.  Primordial odontogenic tumour: clinicopathological analysis of six cases of a previously undescribed entity.

Authors:  Adalberto Mosqueda-Taylor; Fabio Ramoa Pires; José Manuel Aguirre-Urízar; Roman Carlos-Bregni; José Mario de la Piedra-Garza; Rafael Martínez-Conde; Guillermo Martínez-Mata; Sergio J Carreño-Álvarez; Henrique Martins da Silveira; Bruno Santos de Barros Dias; Oslei Paes de Almeida
Journal:  Histopathology       Date:  2014-09-02       Impact factor: 5.087

6.  Clear cell odontogenic carcinomas show EWSR1 rearrangements: a novel finding and a biological link to salivary clear cell carcinomas.

Authors:  Elizabeth A Bilodeau; Ilan Weinreb; Cristina R Antonescu; Lei Zhang; Sanja Dacic; Susan Muller; Bruce Barker; Raja R Seethala
Journal:  Am J Surg Pathol       Date:  2013-07       Impact factor: 6.394

7.  Activating FGFR2-RAS-BRAF mutations in ameloblastoma.

Authors:  Noah A Brown; Delphine Rolland; Jonathan B McHugh; Helmut C Weigelin; Lili Zhao; Megan S Lim; Kojo S J Elenitoba-Johnson; Bryan L Betz
Journal:  Clin Cancer Res       Date:  2014-07-03       Impact factor: 12.531

8.  Marsupialization as a definitive treatment for the odontogenic keratocyst.

Authors:  M Anthony Pogrel; R C K Jordan
Journal:  J Oral Maxillofac Surg       Date:  2004-06       Impact factor: 1.895

9.  Sclerosing odontogenic carcinoma: a previously unreported variant of a locally aggressive odontogenic neoplasm without apparent metastatic potential.

Authors:  Ioannis G Koutlas; Carl M Allen; Gary R Warnock; J Carlos Manivel
Journal:  Am J Surg Pathol       Date:  2008-11       Impact factor: 6.394

10.  Osteosarcomas of the jaws differ from their peripheral counterparts and require a distinct treatment approach. Experiences from the DOESAK Registry.

Authors:  Daniel Baumhoer; Philippe Brunner; Serenella Eppenberger-Castori; Jan Smida; Michaela Nathrath; Gernot Jundt
Journal:  Oral Oncol       Date:  2013-11-15       Impact factor: 5.337

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.